Global Biosimilar Insulin Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilar Insulin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Biosimilar Insulin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Biosimilar Insulin by Country/Region, 2017, 2022 & 2028

2.2 Biosimilar Insulin Segment by Type

2.2.1 Biosimilar Insulin Glargine

2.2.2 Biosimilar Insulin Lispro

2.2.3 Other

2.3 Biosimilar Insulin Sales by Type

2.3.1 Global Biosimilar Insulin Sales Market Share by Type (2017-2022)

2.3.2 Global Biosimilar Insulin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Biosimilar Insulin Sale Price by Type (2017-2022)

2.4 Biosimilar Insulin Segment by Distribution Channel

2.4.1 Hospital

2.4.2 Retail Pharmacy

2.4.3 Others

2.5 Biosimilar Insulin Sales by Distribution Channel

2.5.1 Global Biosimilar Insulin Sale Market Share by Distribution Channel (2017-2022)

2.5.2 Global Biosimilar Insulin Revenue and Market Share by Distribution Channel (2017-2022)

2.5.3 Global Biosimilar Insulin Sale Price by Distribution Channel (2017-2022)

3 Global Biosimilar Insulin by Company

3.1 Global Biosimilar Insulin Breakdown Data by Company

3.1.1 Global Biosimilar Insulin Annual Sales by Company (2020-2022)

3.1.2 Global Biosimilar Insulin Sales Market Share by Company (2020-2022)

3.2 Global Biosimilar Insulin Annual Revenue by Company (2020-2022)

3.2.1 Global Biosimilar Insulin Revenue by Company (2020-2022)

3.2.2 Global Biosimilar Insulin Revenue Market Share by Company (2020-2022)

3.3 Global Biosimilar Insulin Sale Price by Company

3.4 Key Manufacturers Biosimilar Insulin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biosimilar Insulin Product Location Distribution

3.4.2 Players Biosimilar Insulin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Biosimilar Insulin by Geographic Region

4.1 World Historic Biosimilar Insulin Market Size by Geographic Region (2017-2022)

4.1.1 Global Biosimilar Insulin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Biosimilar Insulin Annual Revenue by Geographic Region

4.2 World Historic Biosimilar Insulin Market Size by Country/Region (2017-2022)

4.2.1 Global Biosimilar Insulin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Biosimilar Insulin Annual Revenue by Country/Region

4.3 Americas Biosimilar Insulin Sales Growth

4.4 APAC Biosimilar Insulin Sales Growth

4.5 Europe Biosimilar Insulin Sales Growth

4.6 Middle East & Africa Biosimilar Insulin Sales Growth

5 Americas

5.1 Americas Biosimilar Insulin Sales by Country

5.1.1 Americas Biosimilar Insulin Sales by Country (2017-2022)

5.1.2 Americas Biosimilar Insulin Revenue by Country (2017-2022)

5.2 Americas Biosimilar Insulin Sales by Type

5.3 Americas Biosimilar Insulin Sales by Distribution Channel

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilar Insulin Sales by Region

6.1.1 APAC Biosimilar Insulin Sales by Region (2017-2022)

6.1.2 APAC Biosimilar Insulin Revenue by Region (2017-2022)

6.2 APAC Biosimilar Insulin Sales by Type

6.3 APAC Biosimilar Insulin Sales by Distribution Channel

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Biosimilar Insulin by Country

7.1.1 Europe Biosimilar Insulin Sales by Country (2017-2022)

7.1.2 Europe Biosimilar Insulin Revenue by Country (2017-2022)

7.2 Europe Biosimilar Insulin Sales by Type

7.3 Europe Biosimilar Insulin Sales by Distribution Channel

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilar Insulin by Country

8.1.1 Middle East & Africa Biosimilar Insulin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Biosimilar Insulin Revenue by Country (2017-2022)

8.2 Middle East & Africa Biosimilar Insulin Sales by Type

8.3 Middle East & Africa Biosimilar Insulin Sales by Distribution Channel

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Biosimilar Insulin

10.3 Manufacturing Process Analysis of Biosimilar Insulin

10.4 Industry Chain Structure of Biosimilar Insulin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Biosimilar Insulin Distributors

11.3 Biosimilar Insulin Customer

12 World Forecast Review for Biosimilar Insulin by Geographic Region

12.1 Global Biosimilar Insulin Market Size Forecast by Region

12.1.1 Global Biosimilar Insulin Forecast by Region (2023-2028)

12.1.2 Global Biosimilar Insulin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Biosimilar Insulin Forecast by Type

12.7 Global Biosimilar Insulin Forecast by Distribution Channel

13 Key Players Analysis

13.1 Eli Lilly

13.1.1 Eli Lilly Company Information

13.1.2 Eli Lilly Biosimilar Insulin Product Offered

13.1.3 Eli Lilly Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Eli Lilly Main Business Overview

13.1.5 Eli Lilly Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Biosimilar Insulin Product Offered

13.2.3 Sanofi Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 Gan&Lee

13.3.1 Gan&Lee Company Information

13.3.2 Gan&Lee Biosimilar Insulin Product Offered

13.3.3 Gan&Lee Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Gan&Lee Main Business Overview

13.3.5 Gan&Lee Latest Developments

13.4 Tonghua Dongbao

13.4.1 Tonghua Dongbao Company Information

13.4.2 Tonghua Dongbao Biosimilar Insulin Product Offered

13.4.3 Tonghua Dongbao Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Tonghua Dongbao Main Business Overview

13.4.5 Tonghua Dongbao Latest Developments

13.5 United Laboratory

13.5.1 United Laboratory Company Information

13.5.2 United Laboratory Biosimilar Insulin Product Offered

13.5.3 United Laboratory Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 United Laboratory Main Business Overview

13.5.5 United Laboratory Latest Developments

13.6 Geropharm

13.6.1 Geropharm Company Information

13.6.2 Geropharm Biosimilar Insulin Product Offered

13.6.3 Geropharm Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Geropharm Main Business Overview

13.6.5 Geropharm Latest Developments

13.7 Biocon

13.7.1 Biocon Company Information

13.7.2 Biocon Biosimilar Insulin Product Offered

13.7.3 Biocon Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Biocon Main Business Overview

13.7.5 Biocon Latest Developments

13.8 Wockhardt

13.8.1 Wockhardt Company Information

13.8.2 Wockhardt Biosimilar Insulin Product Offered

13.8.3 Wockhardt Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Wockhardt Main Business Overview

13.8.5 Wockhardt Latest Developments

14 Research Findings and Conclusion

Table 1. Biosimilar Insulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Biosimilar Insulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Biosimilar Insulin Glargine

Table 4. Major Players of Biosimilar Insulin Lispro

Table 5. Major Players of Other

Table 6. Global Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)

Table 7. Global Biosimilar Insulin Sales Market Share by Type (2017-2022)

Table 8. Global Biosimilar Insulin Revenue by Type (2017-2022) & ($ million)

Table 9. Global Biosimilar Insulin Revenue Market Share by Type (2017-2022)

Table 10. Global Biosimilar Insulin Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)

Table 12. Global Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2022)

Table 13. Global Biosimilar Insulin Revenue by Distribution Channel (2017-2022)

Table 14. Global Biosimilar Insulin Revenue Market Share by Distribution Channel (2017-2022)

Table 15. Global Biosimilar Insulin Sale Price by Distribution Channel (2017-2022) & (US$/Unit)

Table 16. Global Biosimilar Insulin Sales by Company (2020-2022) & (K Unit)

Table 17. Global Biosimilar Insulin Sales Market Share by Company (2020-2022)

Table 18. Global Biosimilar Insulin Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Biosimilar Insulin Revenue Market Share by Company (2020-2022)

Table 20. Global Biosimilar Insulin Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Biosimilar Insulin Producing Area Distribution and Sales Area

Table 22. Players Biosimilar Insulin Products Offered

Table 23. Biosimilar Insulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Biosimilar Insulin Sales by Geographic Region (2017-2022) & (K Unit)

Table 27. Global Biosimilar Insulin Sales Market Share Geographic Region (2017-2022)

Table 28. Global Biosimilar Insulin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Biosimilar Insulin Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Biosimilar Insulin Sales by Country/Region (2017-2022) & (K Unit)

Table 31. Global Biosimilar Insulin Sales Market Share by Country/Region (2017-2022)

Table 32. Global Biosimilar Insulin Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Biosimilar Insulin Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Biosimilar Insulin Sales by Country (2017-2022) & (K Unit)

Table 35. Americas Biosimilar Insulin Sales Market Share by Country (2017-2022)

Table 36. Americas Biosimilar Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Biosimilar Insulin Revenue Market Share by Country (2017-2022)

Table 38. Americas Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)

Table 39. Americas Biosimilar Insulin Sales Market Share by Type (2017-2022)

Table 40. Americas Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)

Table 41. Americas Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2022)

Table 42. APAC Biosimilar Insulin Sales by Region (2017-2022) & (K Unit)

Table 43. APAC Biosimilar Insulin Sales Market Share by Region (2017-2022)

Table 44. APAC Biosimilar Insulin Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Biosimilar Insulin Revenue Market Share by Region (2017-2022)

Table 46. APAC Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)

Table 47. APAC Biosimilar Insulin Sales Market Share by Type (2017-2022)

Table 48. APAC Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)

Table 49. APAC Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2022)

Table 50. Europe Biosimilar Insulin Sales by Country (2017-2022) & (K Unit)

Table 51. Europe Biosimilar Insulin Sales Market Share by Country (2017-2022)

Table 52. Europe Biosimilar Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Biosimilar Insulin Revenue Market Share by Country (2017-2022)

Table 54. Europe Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)

Table 55. Europe Biosimilar Insulin Sales Market Share by Type (2017-2022)

Table 56. Europe Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)

Table 57. Europe Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2022)

Table 58. Middle East & Africa Biosimilar Insulin Sales by Country (2017-2022) & (K Unit)

Table 59. Middle East & Africa Biosimilar Insulin Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Biosimilar Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Biosimilar Insulin Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Biosimilar Insulin Sales by Type (2017-2022) & (K Unit)

Table 63. Middle East & Africa Biosimilar Insulin Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Biosimilar Insulin Sales by Distribution Channel (2017-2022) & (K Unit)

Table 65. Middle East & Africa Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Biosimilar Insulin

Table 67. Key Market Challenges & Risks of Biosimilar Insulin

Table 68. Key Industry Trends of Biosimilar Insulin

Table 69. Biosimilar Insulin Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Biosimilar Insulin Distributors List

Table 72. Biosimilar Insulin Customer List

Table 73. Global Biosimilar Insulin Sales Forecast by Region (2023-2028) & (K Unit)

Table 74. Global Biosimilar Insulin Sales Market Forecast by Region

Table 75. Global Biosimilar Insulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Biosimilar Insulin Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Biosimilar Insulin Sales Forecast by Country (2023-2028) & (K Unit)

Table 78. Americas Biosimilar Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Biosimilar Insulin Sales Forecast by Region (2023-2028) & (K Unit)

Table 80. APAC Biosimilar Insulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Biosimilar Insulin Sales Forecast by Country (2023-2028) & (K Unit)

Table 82. Europe Biosimilar Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Biosimilar Insulin Sales Forecast by Country (2023-2028) & (K Unit)

Table 84. Middle East & Africa Biosimilar Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Biosimilar Insulin Sales Forecast by Type (2023-2028) & (K Unit)

Table 86. Global Biosimilar Insulin Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Biosimilar Insulin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Biosimilar Insulin Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Biosimilar Insulin Sales Forecast by Distribution Channel (2023-2028) & (K Unit)

Table 90. Global Biosimilar Insulin Sales Market Share Forecast by Distribution Channel (2023-2028)

Table 91. Global Biosimilar Insulin Revenue Forecast by Distribution Channel (2023-2028) & ($ Millions)

Table 92. Global Biosimilar Insulin Revenue Market Share Forecast by Distribution Channel (2023-2028)

Table 93. Eli Lilly Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 94. Eli Lilly Biosimilar Insulin Product Offered

Table 95. Eli Lilly Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Eli Lilly Main Business

Table 97. Eli Lilly Latest Developments

Table 98. Sanofi Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi Biosimilar Insulin Product Offered

Table 100. Sanofi Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Sanofi Main Business

Table 102. Sanofi Latest Developments

Table 103. Gan&Lee Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 104. Gan&Lee Biosimilar Insulin Product Offered

Table 105. Gan&Lee Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Gan&Lee Main Business

Table 107. Gan&Lee Latest Developments

Table 108. Tonghua Dongbao Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 109. Tonghua Dongbao Biosimilar Insulin Product Offered

Table 110. Tonghua Dongbao Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Tonghua Dongbao Main Business

Table 112. Tonghua Dongbao Latest Developments

Table 113. United Laboratory Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 114. United Laboratory Biosimilar Insulin Product Offered

Table 115. United Laboratory Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. United Laboratory Main Business

Table 117. United Laboratory Latest Developments

Table 118. Geropharm Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 119. Geropharm Biosimilar Insulin Product Offered

Table 120. Geropharm Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Geropharm Main Business

Table 122. Geropharm Latest Developments

Table 123. Biocon Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 124. Biocon Biosimilar Insulin Product Offered

Table 125. Biocon Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Biocon Main Business

Table 127. Biocon Latest Developments

Table 128. Wockhardt Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 129. Wockhardt Biosimilar Insulin Product Offered

Table 130. Wockhardt Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Wockhardt Main Business

Table 132. Wockhardt Latest Developments

List of Figures

Figure 1. Picture of Biosimilar Insulin

Figure 2. Biosimilar Insulin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biosimilar Insulin Sales Growth Rate 2017-2028 (K Unit)

Figure 7. Global Biosimilar Insulin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Biosimilar Insulin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Biosimilar Insulin Glargine

Figure 10. Product Picture of Biosimilar Insulin Lispro

Figure 11. Product Picture of Other

Figure 12. Global Biosimilar Insulin Sales Market Share by Type in 2021

Figure 13. Global Biosimilar Insulin Revenue Market Share by Type (2017-2022)

Figure 14. Biosimilar Insulin Consumed in Hospital

Figure 15. Global Biosimilar Insulin Market: Hospital (2017-2022) & (K Unit)

Figure 16. Biosimilar Insulin Consumed in Retail Pharmacy

Figure 17. Global Biosimilar Insulin Market: Retail Pharmacy (2017-2022) & (K Unit)

Figure 18. Biosimilar Insulin Consumed in Others

Figure 19. Global Biosimilar Insulin Market: Others (2017-2022) & (K Unit)

Figure 20. Global Biosimilar Insulin Sales Market Share by Distribution Channel (2017-2022)

Figure 21. Global Biosimilar Insulin Revenue Market Share by Distribution Channel in 2021

Figure 22. Biosimilar Insulin Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Biosimilar Insulin Revenue Market Share by Company in 2021

Figure 24. Global Biosimilar Insulin Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Biosimilar Insulin Revenue Market Share by Geographic Region in 2021

Figure 26. Global Biosimilar Insulin Sales Market Share by Region (2017-2022)

Figure 27. Global Biosimilar Insulin Revenue Market Share by Country/Region in 2021

Figure 28. Americas Biosimilar Insulin Sales 2017-2022 (K Unit)

Figure 29. Americas Biosimilar Insulin Revenue 2017-2022 ($ Millions)

Figure 30. APAC Biosimilar Insulin Sales 2017-2022 (K Unit)

Figure 31. APAC Biosimilar Insulin Revenue 2017-2022 ($ Millions)

Figure 32. Europe Biosimilar Insulin Sales 2017-2022 (K Unit)

Figure 33. Europe Biosimilar Insulin Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Biosimilar Insulin Sales 2017-2022 (K Unit)

Figure 35. Middle East & Africa Biosimilar Insulin Revenue 2017-2022 ($ Millions)

Figure 36. Americas Biosimilar Insulin Sales Market Share by Country in 2021

Figure 37. Americas Biosimilar Insulin Revenue Market Share by Country in 2021

Figure 38. United States Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Biosimilar Insulin Sales Market Share by Region in 2021

Figure 43. APAC Biosimilar Insulin Revenue Market Share by Regions in 2021

Figure 44. China Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Biosimilar Insulin Sales Market Share by Country in 2021

Figure 51. Europe Biosimilar Insulin Revenue Market Share by Country in 2021

Figure 52. Germany Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Biosimilar Insulin Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Biosimilar Insulin Revenue Market Share by Country in 2021

Figure 59. Egypt Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Biosimilar Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Biosimilar Insulin in 2021

Figure 65. Manufacturing Process Analysis of Biosimilar Insulin

Figure 66. Industry Chain Structure of Biosimilar Insulin

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles